Genomic & Biopharma News

Why can’t Shkreli’s judge find jurors? Prospects blame ‘pharma bro’ for every drug pricing scandal
The New York judge presiding over the case against pharma entrepreneur and investor Martin Shkreli is struggling to find jurors who can be neutral. Shkreli is facing securities fraud charges, but potential jurors are stuck on his drug-pricing past, and they've not been shy about name-calling.
Fierce Pharma, 2017-06-27 13:28:07

Innate immune cells of myeloid lineage play central role in AD pathogenesis than previously thought
Many genes linked to late-onset Alzheimer's disease (AD) are expressed in myeloid cells and regulated by a single protein, according to research conducted at the Icahn School of Medicine at Mount Sinai and published June 19 in the journal Nature Neuroscience.
News Medical Life Sciences, 2017-06-27 13:15:42

Stada's €5.32B buyout bombs, failing to get enough shareholder support
German generics maker Stada is back on the market. Just weeks after announcing a €5.32 billion ($5.63 billion) buyout by private equity investors, the deal has failed, unable to get enough support from shareholders.
Fierce Pharma, 2017-06-27 13:01:25

Despite 'looting' claims, Soon-Shiong’s NantCell to buy Altor
Controversial billionaire biotech entrepreneur Patrick Soon-Shiong says his outfit NantCell will acquire Altor Bioscience for two bucks a share, plus a weighted CVR.
Fierce Biotech, 2017-06-27 12:45:52

Georgian, Insulet, Mayo Clinic get in on Glooko’s $35M series C
Digital diabetes management player Glooko has been on a roll and is showing no signs of stopping. The company has picked up $35 million to further develop its technology and expand in a number of geographic regions.
Fierce Biotech, 2017-06-27 12:31:27

3D printing in medicine
We would normally divide the additive manufacturing technology into seven different groups. Whilst they all focus on building layer by layer, the way in which those layers are constructed varies according to the different type of additive manufacturing technology that's being used.
News Medical Life Sciences, 2017-06-27 12:27:39

Mitoconix Bio hits $20M series A for neurodegenerative R&D
Preclinical startup Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders, including its lead candidate for Huntington’s disease.
Fierce Biotech, 2017-06-27 12:22:39

Lonza says $5.5B deal for Capsugel gets regulatory approvals
Switzerland-based CDMO Lonza said it has been given the green light by regulators for its $5.5 billion deal to buy U.S.-based contract capsule and drug producer Capsugel from KKR.
Fierce Pharma, 2017-06-27 12:13:20

NYC Mayor de Blasio puts up first cash for ambitious life sciences project
New York City's bid to become a life sciences hotspot took another step forward this week with the help of a $5 million grant from the mayor's office.
Fierce Biotech, 2017-06-27 12:05:32